Host-Response Diagnostics: A Novel Validated Approach

We ‘read’ the immune system to characterize disease. The technique works by measuring the expression levels of numerous host immune genes, and then applying proprietary Inflammatix algorithms to produce rapid, clinically actionable results. Our efforts in developing diagnostic tests for acute infection and sepsis have been extensively validated and published in top-tier medical journals. Inflammatix is working with diagnostic instrument ‘platform’ partners to launch the HostDx™ Fever and HostDx™ Sepsis tests.

TEDx Palo Alto: The power of reading the immune system to better diagnose disease

Host-Response-Based Acute Infection Diagnostics for Clinics and Hospitals

Our tests are addressing significant clinical needs in acute infection and sepsis diagnosis that affect millions of people


View from the Top

Perspectives from leaders in acute infection and sepsis care


In the News: Game Changing Impact

Recent notable news stories

August 6, 2019

AACC: Inflammatix sepsis test wins Disruptive Technology contest

Link to story

February 13, 2019

Novel Technologies, Machine Learning Are The Keys To Improving Acute Infection Diagnostics

Link to story

December 27, 2018

New Technologies, Regulatory Approvals Highlight Antimicrobial Resistance Testing in 2018

Link to story

October 28, 2018

Immune Profiling: A New Way to Diagnose Infections

Link to story

Also covered by


Stay in touch with Twitter updates: Find out the latest news.

Connect with Twitter